Extending the limits of globule detection -- ISOPHOT Serendipity Survey Observations of interstellar clouds

A faint $I_{\rm 170}=4$ MJysr$^{-1}$ bipolar globule was discovered with the ISOPHOT 170 $\mu$m Serendipity Survey (ISOSS). ISOSS J 20246+6541 is a cold ($T_{\rm d}\approx 14.5$ K) FIR source without an IRAS pointsource counterpart. In the Digitized Sky Survey B band it is seen as a 3\arcmin size bipolar nebulosity with an average excess surface brightness of $\approx 26$ mag/$\square$\arcsec . The CO column density distribution determined by multi-isotopic, multi-level CO measurements with the IRAM-30m telescope agrees well with the optical appearance. An average hydrogen column density of $\approx 10^{21}$cm$^{-2}$ was derived from both the FIR and CO data. Using a kinematic distance estimate of 400 pc the NLTE modelling of the CO, HCO$^+$, and CS measurements gives a peak density of $\approx 10^4$cm$^{-3}$. The multiwavelength data characterise ISOSS 20246+6541 as a representative of a class of globules which has not been discovered so far due to their small angular size and low 100$\mu$m brightness. A significant overabundance of $^{13}$CO is found $X(^{13}CO) \ge 150\times X(C^{18}O)$. This is likely due to isotope selective chemical processes.Comment: 5 pages, 3 figure

The first CCD photometric study of the open cluster NGC 2126

We present the first CCD photometric observations of the northern open cluster NGC 2126. Data were taken on eight nights in February and December 2002 with a total time span of ~57 hours. Almost 1000 individual V-band frames were examined to find short-period variable stars. We discovered six new variable stars, of which one is a promising candidate for an eclipsing binary with a pulsating component. Two stars were classified as delta Scuti stars and one as Algol-type eclipsing binary. Two stars are slow variables with ambiguous classification. From absolute VRI photometry we have estimated the main characteristics of the cluster: m-M=11.0+/-0.5, E(V-I)=0.4+/-0.1, E(V-R)=0.08+/-0.06 (E(B-V)=0.2+/-0.15) and d=1.3+/-0.6 kpc. Cluster membership is suggested for three variable stars from their positions on the colour-magnitude diagram.Comment: 7 pages, 10 figures, accepted for publication in A&

Cold-induced vasoconstriction at forearm and hand skin sites: the effect of age

During mild cold exposure, elderly are at risk of hypothermia. In humans, glabrous skin at the hands is well adapted as a heat exchanger. Evidence exists that elderly show equal vasoconstriction due to local cooling at the ventral forearm, yet no age effects on vasoconstriction at hand skin have been studied. Here, we tested the hypotheses that at hand sites (a) elderly show equal vasoconstriction due to local cooling and (b) elderly show reduced response to noradrenergic stimuli. Skin perfusion and mean arterial pressure were measured in 16 young adults (Y: 18–28 years) and 16 elderly (E: 68–78 years). To study the effect of local vasoconstriction mechanisms local sympathetic nerve terminals were blocked by bretylium (BR). Baseline local skin temperature was clamped at 33°C. Next, local temperature was reduced to 24°C. After 15 min of local cooling, noradrenalin (NA) was administered to study the effect of neural vasoconstriction mechanisms. No significant age effect was observed in vasoconstriction due to local cooling at BR sites. After NA, vasoconstriction at the forearm showed a significant age effect; however, no significant age effect was found at the hand sites. [Change in CVC (% from baseline): Forearm Y: −76 ± 3 vs. E: −60 ± 5 (P < 0.01), dorsal hand Y: −74 ± 4 vs. E: −72 ± 4 (n.s.), ventral hand Y: −80 ± 7 vs. E: −70 ± 11 (n.s.)]. In conclusion, in contrast to results from the ventral forearm, elderly did not show a blunted response to local cooling and noradrenalin at hand skin sites. This indicates that at hand skin the noradrenergic mechanism of vasoconstriction is maintained with age

Taking connected mobile-health diagnostics of infectious diseases to the field.

Mobile Health or mHealth - The application of mobile devices, their components and related technologies to healthcare is improving patients’ access to treatment and advice. Now, in combination with connected diagnostic devices it offers new possibilities to diagnose, track and control infectious diseases and improve health system efficiencies. In this context we look at these technologies and highlight their promise but also the challenges in realising their potential to increase patient access to testing, aid in their treatment and improve the capability of public health authorities to monitor outbreaks, implement responses, and assess the impact of interventions across the world

Statistical aspects of the TNK-S2B trial of tenecteplase versus alteplase in acute ischemic stroke: an efficient, dose-adaptive, seamless phase II/III design

Background TNK-S2B, an innovative, randomized, seamless phase II/III trial of tenecteplase versus rt-PA for acute ischemic stroke, terminated for slow enrollment before regulatory approval of use of phase II patients in phase III

The Rise and Peak of the Luminous Type IIn SN 2017hcc/ATLAS17lsn from ASAS-SN and Swift UVOT Data

We present observations of the rise and peak of the Type IIn supernova SN 2017hcc/ATLAS17lsn obtained by the All-Sky Automated Survey for Supernovae (ASAS-SN) and Swift UVOT. The light curve of SN 2017hcc/ATLAS17lsn peaks at $V\simeq 13.7$ mag, which from the estimated redshift of the host galaxy ($z=0.0168$, $D\simeq 73$ Mpc) implies an absolute peak magnitude $M_{V,peak} \simeq -20.7$ mag. The near-UV to optical spectral energy distribution of SN 2017hcc/ATLAS17lsn from Swift UVOT is consistent with a hot, but cooling blackbody with $\rm T_{bb}\simeq 16500$ K on Oct. 28.4 and $\rm T_{bb} \simeq 11700$ K on Nov. 19.6. The estimated peak bolometric luminosity $L_{bol, peak}\simeq 1.3\times 10^{44}$ erg s$^{-1}$ makes SN2017hcc/ATLAS17lsn one of the most luminous Type IIn supernovae studied to date. From the bolometric light curve we constrain the risetime to be $\sim 27$ days and the total radiated energy of the event to date is $4\times 10^{50}$ erg

Pan-active imidazolopiperazine antimalarials target the Plasmodium falciparum intracellular secretory pathway.

A promising new compound class for treating human malaria is the imidazolopiperazines (IZP) class. IZP compounds KAF156 (Ganaplacide) and GNF179 are effective against Plasmodium symptomatic asexual blood-stage infections, and are able to prevent transmission and block infection in animal models. But despite the identification of resistance mechanisms in P. falciparum, the mode of action of IZPs remains unknown. To investigate, we here combine in vitro evolution and genome analysis in Saccharomyces cerevisiae with molecular, metabolomic, and chemogenomic methods in P. falciparum. Our findings reveal that IZP-resistant S. cerevisiae clones carry mutations in genes involved in Endoplasmic Reticulum (ER)-based lipid homeostasis and autophagy. In Plasmodium, IZPs inhibit protein trafficking, block the establishment of new permeation pathways, and cause ER expansion. Our data highlight a mechanism for blocking parasite development that is distinct from those of standard compounds used to treat malaria, and demonstrate the potential of IZPs for studying ER-dependent protein processing

Positional cloning of rp2 QTL associates the P450 genes CYP6Z1, CYP6Z3 and CYP6M7 with pyrethroid resistance in the malaria vector Anopheles funestus

Pyrethroid resistance in Anopheles funestus is threatening malaria control in Africa. Elucidation of underlying resistance mechanisms is crucial to improve the success of future control programs. A positional cloning approach was used to identify genes conferring resistance in the uncharacterised rp2 quantitative trait locus (QTL) previously detected in this vector using F6 advanced intercross lines (AIL). A 113 kb BAC clone spanning rp2 was identified and sequenced revealing a cluster of 15 P450 genes and one salivary protein gene (SG7-2). Contrary to A. gambiae, AfCYP6M1 is triplicated in A. funestus, while AgCYP6Z2 orthologue is absent. Five hundred and sixty-five new single nucleotide polymorphisms (SNPs)were identified for genetic mapping from rp2 P450s and other genes revealing high genetic polymorphisms with one SNP every 36 bp. A significant genotype/phenotype association was detected for rp2 P450s but not for a cluster of cuticular protein genes previously associated with resistance in A. gambiae. QTL mapping using F6 AIL confirms the rp2 QTL with an increase logarithm of odds score of 5. Multiplex gene expression profiling of 15 P450s and other genes around rp2 followed by individual validation using qRT–PCR indicated a significant overexpression in the resistant FUMOZ-R strain of the P450s AfCYP6Z1, AfCYP6Z3, AfCYP6M7 and the glutathione-s-transferase GSTe2 with respective fold change of 11.2,6.3, 5.5 and 2.8. Polymorphisms analysis of AfCYP6Z1 and AfCYP6Z3 identified amino acid changes potentially associated with resistance further indicating that these genes are controlling the pyrethroid resistance explained by the rp2 QTL. The characterisation of this rp2 QTL significantly improves our understanding of resistance mechanisms in A. funestus

Haemoptysis in pregnancy caused by a well-differentiated fetal adenocarcinoma: a case report

<p>Abstract</p> <p>Introduction</p> <p>Haemoptysis in pregnancy is frequently assumed to be caused by a pulmonary embolism. However, it can also be an indicator of serious pathology.</p> <p>Case presentation</p> <p>We report the case of a 27-year-old Caucasian woman who presented with haemoptysis in pregnancy that was discovered to be caused by a well-differentiated fetal adenocarcinoma of the lung.</p> <p>Conclusion</p> <p>This case demonstrates the importance of establishing an accurate diagnosis when a pregnant woman presents with haemoptysis and that more serious pathology should be considered if the clinical symptoms persist and/or the presumed diagnosis of pulmonary embolism is not confirmed.</p